Navigation Links
Veils Banned to Muslim medicos in Birmingham Hospital

Adding fuel to the already raging controversy in Britain, Birmingham city hospitals have banned Muslim medicos from donning full-face veils//.

Birmingham University School of Medicine has passed this ban on wearing of a full-face veil by Muslim women in an attempt to "help to aid good communications" between Muslim medical students, their colleagues and patients.

The University will allow Islamic women to cover their faces in lectures and around campus but would not be permitted to do so in the "clinical environments" of hospital buildings and GPs' surgeries. Only in the sterile surroundings of an operating theatre can they cover their faces - with regulation surgical masks.

The ban extends to women Muslim students who has been required to show their faces if they are talking to patients in hospital or surgery or if they are in meetings with other medical staff.

Presently the school has 450 students of all faiths who are sent to practise to a number of different hospitals and primary care units, including the University Hospital of Birmingham NHS Trust.

Birmingham has a large population of Muslims of South Asian origin.

A spokesman said, "We do not place restrictions on the wearing of headscarves by staff or students, except in cases where they are required to work in a clinical environment."

"This is particularly the case when it involves direct contact with patients. In these cases students are allowed to wear a headdress as part of their religious observance, as long as it does not cover the face.”

"This is necessary to help aid communications with patients and other colleagues," the spokesman said.

This move comes close on the heels of a nationwide debate over wearing of veil that was sparked by Commons Leader Jack Straw's comments that he asks Muslim women to remove their veils when they visit his constituency office in Blackburn, northwest England.

'"/>




Page: 1 2

Related medicine news :

1. Drugs Banned worldwide still available in India
2. Smoking Banned In Southeast Asian Games Venues
3. Dentist Banned From Practicing For Allowing Boyfriend to Work on Patients
4. Drug Makers Banned From Providing Gifts To Doctors
5. Gigantic Effort: Smoking To Be Banned in British Telecom’s Offices and Van
6. Chinese Chickens Banned In Hong Kong
7. Abortions Banned In South Dakota
8. Soft Drinks May Be Banned In Rajasthan Schools
9. Pakistan Enforces Strict Bird Flu Measures, Poultry Import Banned
10. Bihar Banned Tobacco Chewing In State Assembly
11. Arrest of Professor over Distribution of Banned Drug
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 3Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 1Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 3Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 4The CLASS Act 3A Retirement In Security 52977 1The CLASS Act 3A Retirement In Security 52977 2